|
Market Closed -
Nasdaq
21:00:00 15/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 1.540 USD | -3.75% |
|
-13.97% | -79.08% |
| 08-31 | Karyopharm Therapeutics Submits Supplemental New Drug Application to the Fda for Xpovio Plus Ruxolitinib for Patients with Myelofibrosis | CI |
| 08-29 | Karyopharm Therapeutics Inc. - Special Call |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| KPTI | Delayed | |
CBOE
| KPTI | Real-time | |
|
Boerse Muenchen
| 25K0 | Real-time | |
|
Deutsche Boerse AG
| 25K0 | Delayed | |
|
Tradegate
| 25K0 | Real-time | |
|
Börse Stuttgart
| 25K0 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 1.81 | 4.03 | 3.85 |
| Spread/Res. | -14.92% | -61.79% | -60.00% |
| Spread/Supp. | +10.01% | +78.49% | +57.29% |
| Support | 1.4 | 0.8628 | 0.9791 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- KPTI Stock
- Charts Karyopharm Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
